The mortality rate for lung cancer is very high.
Lung cancer is one of the most common types of cancer and also has an unusually high mortality rate. It is the second most common cause of cancer death among women and the most common among men. One of the reasons for this is that lung cancer is often diagnosed late, and the disease is usually already very advanced.
Smoking remains the most significant risk factor for lung cancer and is estimated to be responsible for around 85 percent of all cases.
The influence of genes on the risk of lung cancer
The lungs are regularly exposed to harmful environmental influences, such as exhaust fumes from cars. Under normal circumstances, the immune system recognizes and neutralizes them in good time.
However, certain genetic variations in many people lead to this detoxification function of the body not functioning correctly, and thus, the risk of lung cancer increases considerably over time.
How our Lung Health Sensor works
As part of our Lung Health Sensor, our laboratory analyses five genetic variations that have an impact on the risk of lung cancer. The results allow us to assess the individual risk of lung cancer.
We are also testing 40 different drugs to see whether the patient’s genetic profile leads to limitations in terms of efficacy and tolerability.
Once we successfully complete the study, we prepare a written evaluation in which we present all relevant results and give concrete recommendations for any precautionary measures that may be necessary.
In this way, our Lung Health Sensor can help detect lung cancer early and effectively reduce existing risks with the right prevention measures.
The Lung Cancer Sensor at a glance:
- Investigation of 5 gene variations relevant for lung cancer risk
- Assessment of the risk of developing lung cancer
- Evaluation of the effect of 40 drugs based on the gene profile
- Reliable analysis by our laboratory
- Written report with all results
- Concrete recommendations for prevention